Emad
Abuassi
Beijing Anzhen Hospital
Pekín, ChinaPublicacións en colaboración con investigadores/as de Beijing Anzhen Hospital (6)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
2020
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
2018
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
International Journal of Cardiology, Vol. 254, pp. 10-15
-
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Thrombosis and Haemostasis, Vol. 118, Núm. 5, pp. 929-938
2016
-
BleeMACS: Rationale and design of the study
Journal of Cardiovascular Medicine, Vol. 17, Núm. 10, pp. 744-749